"March 24, 2011 - People age 50 and older can now get Merck's Zostavax shingles vaccine, the FDA today ruled.
The vaccine already was approved for people age 60 and older. The approval is based on a Merck clinical trial that showed the"...
Zostavax Consumer (continued)
Some products that may interact with this drug include: cancer chemotherapy, corticosteroids (such as prednisone, dexamethasone), drugs that lower the immune system (such as cyclosporine, tacrolimus), certain antiviral drugs (such as acyclovir, famciclovir, valacyclovir).
OVERDOSE: Overdose with this vaccine is highly unlikely. If overdose is suspected, contact a poison control center or emergency room immediately. US residents can call their local poison control center at 1-800-222-1222. Canada residents can call a provincial poison control center.
NOTES: This vaccine is given as a single dose.
Although this vaccine has been shown to reduce the risk of getting shingles, it may not fully protect everyone who receives the vaccine.
Consult your doctor or pharmacist about the need for other vaccines to prevent potentially severe illness (e.g., flu shots).
MISSED DOSE: Not applicable.
STORAGE: Not applicable. This vaccine is given in a doctor's office and will not be stored at home.
Information last revised October 2013. Copyright(c) 2013 First Databank, Inc.
Additional Zostavax Information
Zostavax - User Reviews
Zostavax User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
Find out what women really need.